| Disease Name |
ICD 11 |
Studied Tissue |
p-value |
Fold-Change |
Z-score |
|
Acute myelocytic leukaemia
|
2B33.1 |
Bone marrow |
2.02E-04
|
1.05E-02
|
6.90E-02 |
|
Alzheimer's disease
|
8A20 |
Entorhinal cortex |
6.17E-04
|
1.66E-01
|
5.17E-01 |
|
Asthma
|
CA23 |
Nasal and bronchial airway |
6.58E-04
|
-3.56E-01
|
-2.61E-01 |
|
Behcet's disease
|
4A62 |
Peripheral blood |
7.61E-01
|
-1.46E-02
|
-4.40E-02 |
|
Bipolar disorder
|
6A60-6A6Z |
Prefrontal cortex |
7.50E-01
|
4.79E-03
|
3.86E-02 |
|
Bladder cancer
|
2C94 |
Bladder tissue |
3.00E-03
|
-9.73E-01
|
-2.35E+00 |
|
Breast cancer
|
2C60-2C6Z |
Breast tissue |
5.70E-04
|
-3.09E-01
|
-3.25E-01 |
|
Colon cancer
|
2B90 |
Colon tissue |
1.88E-57
|
-1.96E+00
|
-2.17E+00 |
|
Diffuse large B-cell lymphoma
|
2A81 |
Tonsil tissue |
6.56E-01
|
1.34E-01
|
8.80E-01 |
|
Familial hypercholesterolemia
|
5C80.00 |
Peripheral blood |
4.35E-01
|
-1.27E-01
|
-7.55E-01 |
|
Gastric cancer
|
2B72 |
Gastric tissue |
3.28E-01
|
-1.46E+00
|
-8.73E-01 |
|
Glioblastopma
|
2A00.00 |
Nervous tissue |
5.39E-02
|
-4.98E-02
|
-1.47E-01 |
|
Head and neck cancer
|
2D42 |
Head and neck tissue |
3.29E-13
|
-4.23E-01
|
-3.03E-01 |
|
HIV-associated neurocognitive impairment
|
8A2Y-8A2Z |
White matter tissue |
8.10E-01
|
-1.13E-02
|
-4.86E-02 |
|
Idiopathic pulmonary fibrosis
|
CB03.4 |
Lung tissue |
4.31E-03
|
-2.49E+00
|
-2.84E+00 |
|
Interstitial cystitis
|
GC00.3 |
Bladder tissue |
1.96E-03
|
-7.53E-01
|
-2.23E+00 |
|
Ischemic stroke
|
8B11 |
Peripheral blood |
3.68E-01
|
-4.26E-02
|
-9.37E-02 |
|
Liver cancer
|
2C12.0 |
Liver tissue |
6.70E-05
|
-3.68E-01
|
-4.91E-01 |
|
Liver failure
|
DB99.7-DB99.8 |
Liver tissue |
3.67E-03
|
-2.68E+00
|
-8.50E+00 |
|
Lung cancer
|
2C25 |
Lung tissue |
7.69E-06
|
-7.75E-01
|
-7.95E-01 |
|
Lupus erythematosus
|
4A40 |
Whole blood |
1.40E-02
|
1.58E-01
|
2.54E-01 |
|
Major depressive disorder
|
6A70-6A7Z |
Hippocampus |
1.48E-01
|
-5.42E-02
|
-4.28E-01 |
|
Multiple myeloma
|
2A83.1 |
Bone marrow |
1.03E-01
|
-6.22E-02
|
-8.20E-01 |
|
Multiple myeloma
|
2A83.1 |
Peripheral blood |
3.62E-01
|
1.67E-02
|
1.07E-01 |
|
Multiple sclerosis
|
8A40 |
Plasmacytoid dendritic cells |
3.65E-01
|
-2.39E-01
|
-4.89E-01 |
|
Myelodysplastic syndrome
|
2A36-2A3Z |
Bone marrow |
1.35E-03
|
1.40E-01
|
5.47E-01 |
|
Myocardial infarction
|
BA41-BA50 |
Peripheral blood |
4.88E-01
|
2.01E-02
|
2.98E-02 |
|
Neuroectodermal tumour
|
2A00.11 |
Brain stem tissue |
3.70E-05
|
-7.40E-01
|
-2.38E+00 |
|
Non-alcoholic fatty liver disease
|
DB92 |
Liver tissue |
3.17E-01
|
1.38E-01
|
8.90E-02 |
|
Obesity related type 2 diabetes
|
5A11 |
Omental adipose tissue |
7.73E-01
|
4.29E-02
|
4.77E-01 |
|
Olive pollen allergy
|
CA08.00 |
Peripheral blood |
5.93E-01
|
-1.14E-02
|
-6.71E-02 |
|
Oral cancer
|
2B6E |
Oral tissue |
2.62E-01
|
-9.10E-02
|
-2.37E-01 |
|
Ovarian cancer
|
2C73 |
Ovarian tissue |
2.52E-02
|
-5.33E-01
|
-1.89E+00 |
|
Pancreatic cancer
|
2C10 |
Pancreas |
5.80E-01
|
-1.95E-01
|
-1.49E-01 |
|
Parkinson's disease
|
8A00.0 |
Substantia nigra tissue |
3.48E-01
|
1.31E-01
|
4.21E-01 |
|
Pituitary cancer
|
2D12 |
Pituitary tissue |
4.64E-02
|
-2.64E-01
|
-4.65E-01 |
|
Polycystic ovary syndrome
|
5A80.1 |
Vastus lateralis muscle |
3.54E-01
|
-4.37E-02
|
-4.52E-01 |
|
Pompe disease
|
5C51.3 |
Biceps muscle |
1.19E-01
|
-5.23E-02
|
-3.06E-01 |
|
Prostate cancer
|
2C82 |
Prostate |
9.33E-06
|
8.14E-01
|
1.21E+00 |
|
Psoriasis
|
EA90 |
Skin |
3.39E-10
|
-6.95E-01
|
-1.12E+00 |
|
Rectal cancer
|
2B92 |
Rectal colon tissue |
3.77E-03
|
-1.57E+00
|
-1.97E+00 |
|
Renal cancer
|
2C90-2C91 |
Kidney |
2.82E-03
|
-1.08E+00
|
-1.46E+00 |
|
Retinoblastoma
|
2D02.2 |
Uvea |
9.41E-01
|
-3.99E-02
|
-9.02E-01 |
|
Schizophrenia
|
6A20 |
Prefrontal cortex |
6.82E-03
|
1.23E-01
|
5.05E-01 |
|
Schizophrenia
|
6A20 |
Superior temporal cortex |
5.48E-01
|
-1.43E-02
|
-1.39E-01 |
|
Scleroderma
|
4A42.Z |
Whole blood |
1.77E-02
|
1.50E-01
|
1.10E+00 |
|
Seizure
|
8A60-8A6Z |
Whole blood |
3.36E-01
|
-8.63E-02
|
-2.62E-01 |
|
Sepsis with septic shock
|
1G41 |
Whole blood |
4.60E-03
|
-1.97E-02
|
-5.80E-02 |
|
Sickle cell disease
|
3A51.0-3A51.3 |
Peripheral blood |
3.11E-02
|
1.29E-01
|
1.05E+00 |
|
Simpson golabi behmel syndrome
|
LD2C |
Adipose tissue |
8.14E-01
|
0.00E+00
|
0.00E+00 |
|
Sjogren's syndrome
|
4A43.2 |
Salivary gland tissue |
5.86E-01
|
-1.64E-01
|
-3.07E-01 |
|
Skin cancer
|
2C30-2C3Z |
Skin |
3.50E-59
|
-1.35E+00
|
-1.71E+00 |
|
Thrombocythemia
|
3B63 |
Whole blood |
3.61E-03
|
2.90E-02
|
1.15E-01 |
|
Thrombocytopenia
|
3B64 |
Whole blood |
7.18E-01
|
-2.32E-03
|
-5.77E-03 |
|
Thyroid cancer
|
2D10 |
Thyroid |
5.27E-18
|
2.50E-01
|
1.22E+00 |
|
Tibial muscular dystrophy
|
8C75 |
Muscle tissue |
9.51E-01
|
1.78E-02
|
1.22E-01 |
|
Tuberous sclerosis complex
|
LD2D.2 |
Perituberal tissue |
7.26E-02
|
1.36E-01
|
1.85E+00 |
|
Type 2 diabetes
|
5A11 |
Liver tissue |
7.79E-01
|
3.24E-02
|
7.01E-02 |
|
Ureter cancer
|
2C92 |
Urothelium |
8.18E-01
|
5.28E-02
|
2.06E-01 |
|
Uterine cancer
|
2C78 |
Endometrium tissue |
1.83E-02
|
-1.23E-01
|
-3.36E-01 |
|
Vitiligo
|
ED63.0 |
Skin |
7.21E-01
|
-1.76E-03
|
-2.74E-03 |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
